Invesco Ltd. Alvotech Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Alvotech stock. As of the latest transaction made, Invesco Ltd. holds 23,604 shares of ALVO stock, worth $230,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,604
Previous 11,210
110.56%
Holding current value
$230,847
Previous $147,000
55.1%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALVO
# of Institutions
50Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$41 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$26.5 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$18.3 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$13.7 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12.9 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.43B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...